ArticleJournal of natural medicines2026
Biological activity of isomalabaricane compounds from the marine sponge Rhabdastrella globostellata.
Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the cytotoxic effects of isomalabaricane stellettins Q-V and globostelletins K-N, recently isolated from the Vietnamese marine sponge Rhabdastrella globostellata, against human cervical cancer HeLa, human melanoma SK-Mel-28, murine neuroblastoma Neuro-2a cells, human normal keratinocytes HaCaT, and rat normal cardiomyocytes H9c2, as well as to study the cardioprotective activity of non-toxic compounds. Stellettins Q and R and globostelletins M and N showed moderate cytotoxic activity against HeLa, SK-Mel-28, Neuro-2a cells as well as normal keratinocytes HaCaT and normal cardiomyocytes H9c2. Stellettin U increased the viability of H9c2 cardiomyocytes treated with nutrient deprivation, high concentration of ATP, TNF-α pro-inflammatory cytokine, and CoCl2-mimicking hypoxia. In an in vitro ischemia model, stellettin U reversed mitochondrial ROS and cardiolipin peroxidation levels. In CoCl2-induced toxicity, intracellular and mitochondrial ROS production, mitochondrial membrane depolarization, and cardiolipin peroxidation levels were normalized following stellettin U treatment. The effect of stellettin U on ATP-induced Ca2+influx led to the assumption that stellettin U protects cardiomyocytes via a P2X7R-dependend pathway. Moreover, the modulation of the NF-κB-dependent anti-inflammatory pathway by stellettin U was confirmed. Thus, it was suggested that stellettin U may protect cardiomyocytes via both canonical NF-κB- and non-canonical P2X7R-dependend pathways.
Indexed as
Identifiers
41865145What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.